FocalTherics 

$4.71
6
-$0.08-1.67% 今天

統計

當日最高
4.8
當日最低
4.65
52週高點
5.05
52週低點
1.21
成交量
127,392
平均成交量
-
市值
176.34M
本益比
-
股息殖利率
-
股息
-

財報

28Aug預期
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.15
-0.1
-0.05
預期EPS
-0.18
實際EPS
-0.17

財務

-29.94%利潤率
未盈利
2019
2020
2021
2022
2023
2024
137.96M營收
-41.31M淨利

分析師評級

10.00平均目標價
最高預估為 10.00。
來自過去6個月內的 2 則評分。這不是投資建議。
買入
100%
持有
0%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 EDAP 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

EDAP TMS S.A., a medical technology firm headquartered in Lyon, France, since its inception in 1979, innovates, manufactures, and globally distributes advanced, minimally invasive medical devices. With a primary focus on addressing urological diseases through sophisticated solutions, the company operates across Asia, France, the United States, and other international markets. Its business operations are divided into three distinct segments: 1. High Intensity Focused Ultrasound (HIFU): This segment concentrates on developing and advancing HIFU technology for the minimally invasive treatment of urological and various other clinical indications. Its product portfolio encompasses the Ablatherm, an ultrasound-guided robotic HIFU device for organ-confined prostate cancer; the Ablatherm Fusion, which features proprietary fusion software that merges MRI and ultrasound images for precise targeting; and the Focal One, a robotic HIFU device specifically designed for the focal therapy of prostate cancer. The segment also provides necessary disposables, leasing and treatment-related services, and ongoing maintenance. 2. Extracorporeal ShockWave Lithotripsy (ESWL): This division is responsible for manufacturing and marketing lithotripters utilizing ESWL technology to treat urinary tract stones. Its flagship, the Sonolith i-move, is an extracorporeal shockwave lithotripter well-suited for small to mid-sized hospitals, with accompanying sales of disposable parts and electrodes. 3. Distribution Services (DIST): This segment oversees the marketing, distribution, and servicing of various medical products from third-party manufacturers, such as lasers and micro-ultrasound systems. This segment's offerings also extend to device leasing, the sale of disposables and spare parts, and comprehensive maintenance support. The company serves a broad customer base, including hospitals, urology clinics, and research institutions, leveraging both its direct marketing, sales, and service platform, as well as a network of third-party distributors and agents.
Show more...
執行長
Mr. Ryan Rhodes
員工
310
國家
法國
ISIN
US2683111072

上市

0 Comments

分享你的想法

FAQ

FocalTherics 今天的股價是多少?
EDAP 目前價格為 $4.71 USD,過去 24 小時下跌了 -1.67%。在圖表上更密切關注 FocalTherics 股票的表現。
FocalTherics 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,FocalTherics 的股票以代號 EDAP 進行交易。
FocalTherics 的股價在上漲嗎?
EDAP 股票較上週上漲 +2.84%,本月上漲 +12.95%,過去一年 FocalTherics 上漲 +170.69%。
FocalTherics 的市值是多少?
今天 FocalTherics 的市值為 176.34M
FocalTherics 上一季度的財報如何?
EDAP 上一季度的財報為每股 -0.17 USD,預估為 -0.18 USD,帶來 +5.56% 的驚喜。下一季度的預估財報為每股 不適用 USD。
FocalTherics 去年的營收是多少?
FocalTherics 去年的營收為 137.96MUSD。
FocalTherics 去年的淨利是多少?
EDAP 去年的淨收益為 -41.31MUSD。
FocalTherics 有多少名員工?
截至 June 16, 2026,公司共有 310 名員工。
FocalTherics 位於哪個產業?
FocalTherics從事於Health & Wellness產業。
FocalTherics 何時完成拆股?
FocalTherics 最近沒有進行任何拆股。
FocalTherics 的總部在哪裡?
FocalTherics 的總部位於 法國 的 Vaulx-en-Velin。